SEARCH:   Advanced

Blood, Vol. 112, Issue 13, 5095-5102, December 15, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3 Blood Nelson et al. 112: 5095 Supplemental materials for: Nelson et al Files in this Data Supplement: Table S1. Relative inhibition of STAT3 phosphorylation at doses of Jak kinase inhibitors that cause equal inhibition of viability of INA6 multiple myeloma cells (PDF, ) Figure S1 (JPG, 24.6 KB) - U266 cells were cultured in the presence or absence of BMSC for 6 hours with the indicated concentrations of nifuroxazide, and then examined by Western analysis with antibodies for (A) MAP kinase and phosphorylated MAP kinase, or (B) Akt and phosphorylated Akt. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020